Fintel reports that on November 25, 2025, HC Wainwright & Co. maintained coverage of BiomX (NYSEAM:PHGE) with a Buy recommendation.
Analyst Price Forecast Suggests 5,376.27% Upside
As of November 17, 2025, the average one-year price target for BiomX is $15.81/share. The forecasts range from a low of $15.15 to a high of $16.80. The average price target represents an increase of 5,376.27% from its latest reported closing price of $0.29 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for BiomX is 0MM. The projected annual non-GAAP EPS is -0.81.
What is the Fund Sentiment?
There are 22 funds or institutions reporting positions in BiomX. This is an increase of 1 owner(s) or 4.76% in the last quarter. Average portfolio weight of all funds dedicated to PHGE is 0.01%, an increase of 72.79%. Total shares owned by institutions decreased in the last three months by 23.32% to 8,311K shares.
What are Other Shareholders Doing?
Deerfield Management Company, L.p. holds 2,494K shares representing 8.60% ownership of the company. No change in the last quarter.
Nantahala Capital Management holds 2,493K shares representing 8.60% ownership of the company. No change in the last quarter.
Alyeska Investment Group holds 1,591K shares representing 5.48% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Jpmorgan Chase holds 430K shares representing 1.48% ownership of the company. No change in the last quarter.
DAFNA Capital Management holds 401K shares representing 1.38% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
